What is the recommendation for using icosapent ethyl for primary prevention in patients on statin therapy with persistently elevated fasting triglycerides?
For primary prevention, there is insufficient evidence to recommend for or against icosapent ethyl in patients on statin therapy with persistently elevated fasting triglycerides. Neither for nor against